Advanced imaging technology offers the promise of breakthroughs in medical diagnosis. Focusing on the retina, it can reveal each photoreceptor cell and show dynamic images of blood flow. The development of this technology could enable doctors to spot signs of eye diseases and glean insight into lifestyle-related diseases.

Such technologies, in fact, are already in development through the CK Project, a joint research project between Canon and Kyoto University, which conducts clinical research for the commercialization of leading-edge medical imaging technologies.

The CK Project supported the establishment of the Advanced Medical Device Development and Clinical Research Center, which works with Kyoto University to develop equipment for its clinical research. Already under development is optical ultrasound mammography, which can facilitate the very early detection of breast cancer, from which there is a 95% recovery rate when caught early.

Although commonly associated with enjoyment, Canon's imaging technology is opening new business paths in the medical industry. Digital radiography, for instance, enables the confirmation of X-ray images seconds after exposure. Boosting resolution and sensitivity, Canon is targeting the No.1 spot in the industry.

On other fronts, OPTOPOL Technology S.A., a Canon Group Company since 2010, works with Canon to develop leading-edge optical coherence tomography and other ophthalmic diagnostic equipment. In the U.S., Canon is involved in operation test research with universities for the commercialization of DNA diagnostic devices that may shed new light on the efficacy and side effects of pharmaceuticals.

In these ways, Canon is applying leading-edge imaging technology toward making people's lives healthier.